Neuropeptide Y shifts equilibrium between and β-adrenergic tonus in proximal tubule cells

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 1 44-1, 1998, Pages

  Holtbäck, Ulla ^a,b   Ohtomo, Yoshiyuki ^a   Förberg, Petter ^a   Sahlgren, Bo ^a   Aperia, Anita ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Adrenergic cotransmitter; Kidney; Norepinephrine; Sodium potassium adenosinetriphosphatase activity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; ISOPRENALINE; NEUROPEPTIDE Y; NORADRENALIN; OXYMETAZOLINE;

ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SODIUM ABSORPTION;

EID: 0031868840     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Abdulnour-Nakhoul, S., R. N. Khuri, and N. L. Nakhoul. Effect of norepinephrine on cellular sodium transport in Ambystoma kidney proximal tubule. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F725-F736, 1994.
2. Agnati L. F., S. Ferre, P. Cortelli, and K. Fuxe. A brief appraisal on some aspects of the receptor-receptor interaction. Neurochem. Int. 27: 139-146, 1995.
3. Agnati L. F., K. Fuxe, F. Benfenati, G. von Euler, and B. Fredholm. Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system. Neurochem. Int. 22: 213-222, 1993.
4. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J. 8: 436-439, 1994.
5. +-ATPase activity in renal tubule cells. Proc. Natl. Acad. Sci. USA 89: 7394-7397, 1992.
6. +-ATPase and solute transport in rabbit proximal tubules. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F215-F220, 1987.
7. Bello-Reuss, E., R. E. Colindres, E. Pastoriza-Munoz, R. A. Mueller, and C. W. Gottshalk. Effects of acute unilateral renal denervation in the rat. J. Clin. Invest. 56: 208-217, 1975.
8. 2 receptors. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F924-F928, 1990.
9. Bjenning, C., S. Holmgren, and A. P. Farrell. Neuropeptide Y potentiates contractile response to norepinephrine in skate coronary artery. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H661-H665, 1993.
10. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
11. DiBona, G. F. Neural regulation of renal tubular sodium reabsorption and renin secretion. Federation Proc. 44: 12816-2822, 1985.
12. Ekblad, E., L. Edvinson, C. Wahlstedt, R. Uddman, R. Håkansson, and F. Sundler. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibres. Regul. Pept. 8: 225-235, 1984.
13. Fallgren, B., P. Arlock, and L. Edvinsson. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism. J. Auton. Nerv. Syst. 44: 151-159, 1993.
14. Ferre, S., P. Popoli, L. Gimenez-Llort, U. B. Finnman, E. Martinez, A. Scotti de Carolis, and K. Fuxe. Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. Neuroreport 6: 73-76, 1994.
15. Fredholm, B. B., J. Häggblad, A. Häfstrand, and O. Larsson. Tissue differences in the effect of neuropeptide Y, adenosine and noradrenaline at the second messenger level. In: Neuropeptide Y. New York: Raven, 1989, p. 181-189.
16. Fried, G., L. Terenius, T. Hökfelt, and M. Goldstein. Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. Neuroscience 5: 450-458, 1984.
17. Gilman, A. G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56: 615-649, 1987.
18. 2+ in smooth muscles. Nature 329: 333-335, 1987.
19. Hanson, A. S., and S. L. Linas. β-Adrenergic receptor function in rat proximal tubule epithelial cells in culture. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F553-F560, 1995.
20. Harada, Y., M. Okubo. K. Yaga, T. Kaneko, and K. Kaku. Neuropeptide Y inhibits β-adrenergic agonist- and vasoactive intestinal peptide-induced cyclic AMP accumulation in rat pinealocytes through pertussis toxin-sensitive G protein. J. Neurochem. 59: 2178-2183, 1992.
21. Harris, K. M., and P. Sultan. Variation in the number, location and size of synaptic vesicles provides an anatomical basis for the nonuniform probability of release at hippocampal CA1 synapses. Neuropharmacology 34: 1387-1395, 1995.
22. 2-receptors on proximal tubules of rat and rabbit kidney. J. Cardiovasc. Pharmacol. 7: 9-17, 1985.
23. +-ATPase activity in rat proximal tubule after high protein diet. Acta Physiol. Scand. 139: 9-13, 1990.
24. Londos, C., and J. Wolff. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. USA 74: 5482-5486, 1977.
25. Lundberg, J. M., J. Pernow, and J. S. Lacroix. Neuropeptide Y: sympathetic cotransmitter and modulator? News Physiol. Sci. 4: 13-17, 1989.
26. Lundberg, J. M., L. Terenius, T. Hökfelt, and M. Goldstein. High levels of neuropeptide Y (NPY) in peripheral noradrenergic neurones in various mammals including man. Neurosci. Lett. 52: 167-172, 1983.
27. 2 receptors in a human neuroblastoma cell line. J. Biol. Chem. 269: 8226-8233, 1994.
28. Meister, B., Å. Dagerlind, A. P. Nicholase, and T. Hökfelt. Patterns of messenger RNA expression for adrenergic receptor subtypes in rat kidney. J. Pharmacol. Exp. Ther. 268: 1605-1611, 1994.
29. 2+. Pharmacol. Rev. 40: 87-119, 1988.
30. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21: 767-771, 1993.
31. +-ATPase activity. Kidney Int. 45: 1606-1613, 1994.
32. +-ATPase. Pediatr. Res. 39: 534-538, 1996.
33. Olasmaa, M., S. Påhlman, and L. Terenius. β-Adrenoceptor, vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) receptors functionally coupled to adenylate cyclase in the human neuroblastoma SK-N-MC cell line. Neurosci. Lett. 83: 161-166, 1987.
34. Potter, E. K. Neuropeptide Y as an autonomic neurotransmitter. Pharmacol. Ther. 37: 251-273, 1988.
35. Raymond, J. R., M. Hnatowich, R. J. Lefkowitz, and M. G. Caron. Adrenergic receptors. Models for regulation of signal transduction processes. Hypertension 15: 119-131, 1990.
36. Sadler, S. E., and L. Maller. Inhibition of Xenopus oocyte adenylate cyclase by progesterone and 2′,5′-dideoxyadenosine is associated with slowing guanine nucleotide exchange. J. Biol. Chem. 258: 7935-7941, 1983.
37. 2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol. 26): F978-F984, 1989.
38. Shigeri, Y., and M. Fujimoto. Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line. J. Biol. Chem. 269: 8842-8848, 1994.
39. Stjärne, L., and E. Stjärne. Geometry, kinetics and plasticity of release and clearance of ATP and noradrenaline as sympathetic cotransmitters: roles for the neurogenic contraction. Prog. Neurobiol. 47: 45-94, 1995.
40. Waeber, B. Cardiovascular effects of neuropeptide Y. Am. J. Hypertens. 1: 193-199, 1988.
41. Wan, C. P., and B. H. Lau. Neuropeptide Y receptor subtypes. Life Sci. 56: 1055-1064, 1995.
42. Woo, N. D., D. S. C. Lam, J. A. Hays, V. Panagia, and P. K. Ganguly. Adrenoreceptor-mediated effect of neuropeptide Y decreases cardiac inotropic responses. Biochim. Biophys. Acta 1222: 457-463, 1994.